Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?

被引：23

作者：

Kumarasamy, N. ^{[1
,3
]}

Patel, Atul ^{[2
,3
]}

Pujari, Sanjay ^{[3
,4
]}

机构：

[1] YRG CARE Med Ctr, Voluntary Hlth Serv, Madras 600113, Tamil Nadu, India

[2] Vedant Inst Med Sci, Ahmadabad, Gujarat, India

[3] Inst Infect Dis, Pune, Maharashtra, India

[4] HIVMAI, Pune, Maharashtra, India

来源：

INDIAN JOURNAL OF MEDICAL RESEARCH | 2011年 / 134卷 / 06期

基金：

英国惠康基金;

关键词：

Antiretroviral drugs; antiretroviral therapy; ART; CD4; HIV; IRIS; viral load; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED PATIENTS; CD4 CELL COUNTS; COST-EFFECTIVENESS ANALYSIS; ZIDOVUDINE-INDUCED ANEMIA; LONG-TERM EFFICACY; LINE VIRAL LOAD; IMMUNE RECONSTITUTION; RISK-FACTORS; DRUG-RESISTANCE;

D O I：

10.4103/0971-5916.92626

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

With the rapid scale up of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Several new safe antiretroviral, and newer class of drugs and monitoring assays are developed recently. As a result the treatment guideline for the management of HIV disease continue to change. This review focuses on evolving science on Indian policy - antiretroviral therapy initiation, which drugs to start with, when to change the initial regimen and what to change.

引用

页码：787 / 800

页数：14

共 50 条

[31] When to start antiretroviral therapy in adults in low-income and middle-income countries: science and practice
Munderi, Paula
CURRENT OPINION IN HIV AND AIDS, 2010, 5 (01) : 6 - 11
[32] What Time is it? Adherence to Antiretroviral Therapy in Ethiopia
Yordanos M. Tiruneh
Ira B. Wilson
AIDS and Behavior, 2016, 20 : 2662 - 2673
[33] Broadening the Perspective when Assessing Evidence on Boosted Protease Inhibitor-Based Regimens for Initial Antiretroviral Therapy
Hornberger, John
Simpson, Kit
Shewade, Ashwini
Dietz, Birgitta
Baran, Robert
Podsadecki, Thomas
ADVANCES IN THERAPY, 2010, 27 (11) : 763 - 773
[34] When is the best time to initiate antiretroviral therapy?
Borges, Alvaro H.
Lundgren, Jens D.
LANCET HIV, 2015, 2 (08): : E312 - E313
[35] Antiretroviral Therapy: What to Look Out For!
Uppala, Divya
Majumdar, Sumit
Reddy, Lokesh
Suresh, Aparnna
ORAL & MAXILLOFACIAL PATHOLOGY JOURNAL, 2014, 5 (01) : 429 - 433
[36] WHAT IS THE VERSE? / WHEN IS A LINE A VERSE?
Torre, Esteban
RHYTHMICA-REVISTA ESPANOLA DE METRICA COMPARADA, 2009, (07): : 135 - 149
[37] Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown
M. Eugenia Socias
M-J Milloy
Current Infectious Disease Reports, 2018, 20
[38] Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown
Socias, M. Eugenia
Milloy, M-J
CURRENT INFECTIOUS DISEASE REPORTS, 2018, 20 (09)
[39] A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
Agnes N. Kiragga
Frank Mubiru
Andrew D. Kambugu
Moses R. Kamya
Barbara Castelnuovo
BMC Infectious Diseases, 19
[40] HIV recombination: what is the impact on antiretroviral therapy?
Fraser, C
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2005, 2 (05) : 489 - 503

← 1 2 3 4 5 →